Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Colorectal Dis. 2009 Jan 27;12(3):213–219. doi: 10.1111/j.1463-1318.2009.01779.x

Table 1.

Loss of SMAD4 protein expression in early-onset colorectal cancers.

Total SMAD4 staining (%)
Positive Negative
Tumour site
 colonic tumours 66 55 (83) 11 (17)
  Right colon 35 30 (86) 5 (14)
  Splenic flexure 2 1 (50) 1 (50)
  Left colon 29 24 (83) 5 (17)
 Rectal tumours 41 26 (63) 15 (36)*
 Site unknown 2 1 1
 Total tumours 109 82 (75) 27 (25)
TGFβR11
 Frameshift mutation 21 18 (86) 3 (14)
 No mutations 82 61 (74) 21 (26)
 No data 6 3 3
 Total 109 82 27
SMAD4 gene copy number
 Loss of copy number 27 14 (51) 13 (48)
 No change 21 9 (42) 12 (544)
 Gain of copy number 4 4 (100) 0
 No data 4 2 (50) 2 (50)
 Total 56 29 27
MSI
 MSI-High 17 14 (82)* 3 (18)
 MSI-Low 18 13 (72) 5 (28)
 MSS 70 52 (74) 18 (26)
 No data 4
 Total 109 82 27

Loss of SMAD4 protein expression was more common in tumours diagnosed in the rectum than in the colon (P = 0.04).

*

Ten patients with early-onset colorectal cancer had germ-line mutations in MMR genes (8 in MLH1 and 2 in MSH2).

Four patients with early-onset colorectal cancer had germ-line mutations in MSH6.

All three patients with early-onset colorectal cancer had germ-line mutations in MMR genes (1 in MLH1 and 2 in MSH2).